TrialRenal failure2025

The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention.

Chunyang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.